MedPath

IRCCS SAN RAFFAELE ROMA SRL

🇮🇹Italy
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.poliambulatorisanraffaele.it/it/sedi/san-raffaele-pisana

Activity of Platelets After Inhibition and Cardiovascular Events Optical Coherence Tomography Study

Phase 3
Completed
Conditions
Acute Coronary Syndrome
Interventions
Device: stent implantation
First Posted Date
2010-11-11
Last Posted Date
2012-05-23
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
60
Registration Number
NCT01239654
Locations
🇮🇹

Università della Magna Grecia, Catanzaro, Italy

🇮🇹

Careggi Hospital, Florence, Italy

🇮🇹

San Raffaele Hospital, Milan, Italy

and more 1 locations

Heart Rate Reduction in Heart Failure

Phase 3
Completed
Conditions
Heart Failure
Interventions
First Posted Date
2010-08-10
Last Posted Date
2014-09-30
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
121
Registration Number
NCT01178528
Locations
🇮🇹

Centre for Clinical and Basic Research - IRCCS San Raffaele, Roma, Italy

🇮🇹

IRCCS San Raffaele, Roma, Italy

Carbohydrate Counting in Adults With Type 1 Diabetes Treated With Continuous Subcutaneous Insulin Infusion

Phase 3
Completed
Conditions
Diabetes Mellitus, Type 1
Insulin Pump, Programmable
Interventions
Behavioral: Carbohydrate counting training
First Posted Date
2010-08-03
Last Posted Date
2010-08-03
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
61
Registration Number
NCT01173991
Locations
🇮🇹

San Raffaele Scientific Institute, Milano, Italy

Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer

Phase 2
Terminated
Conditions
Pancreatic Cancer
Interventions
First Posted Date
2010-07-22
Last Posted Date
2015-04-24
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
60
Registration Number
NCT01167738
Locations
🇮🇹

Istituto Scientifico H. San Raffaele, Milan, Italy

Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic Cancer

Phase 2
Completed
Conditions
Pancreatic Cancer
Interventions
First Posted Date
2010-06-25
Last Posted Date
2017-09-01
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
98
Registration Number
NCT01150630
Locations
🇮🇹

Istituto Scientifico H. San Raffaele, Milan, Italy

Normalization of Fasting Glucose and the Incidence of Restenosis After Peripheral Angioplasty

Phase 4
Terminated
Conditions
Type 2 Diabetes Mellitus
Peripheral Vascular Disease
Interventions
Drug: Insulin glargine plus insulin analogues
First Posted Date
2010-06-25
Last Posted Date
2012-09-13
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
46
Registration Number
NCT01150617
Locations
🇮🇹

Cardio-Metabolic and Clinical Trials Unit, San Raffaele Scientific Institute, Milan, Italy

Pre Transplant Rapamycin Treatment in Islet Transplantation Alone

Phase 3
Completed
Conditions
Diabetes Mellitus, Type 1
Interventions
First Posted Date
2010-02-02
Last Posted Date
2010-02-02
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
11
Registration Number
NCT01060605
Locations
🇮🇹

Transplant Unit, IRCCS San Raffaele, Milano, Italy

Maintenance Therapy With Sunitinib or Observation in Metastatic Pancreatic Cancer

Phase 2
Completed
Conditions
Pancreatic Cancer
Interventions
First Posted Date
2009-08-28
Last Posted Date
2012-02-01
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
56
Registration Number
NCT00967603
Locations
🇮🇹

San Raffaele Scientific Institute, Milan, Italy

Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic Cancer

Phase 2
Terminated
Conditions
Pancreatic Cancer
First Posted Date
2009-08-27
Last Posted Date
2012-02-01
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
21
Registration Number
NCT00967291
Locations
🇮🇹

Istituto Scientifico H. San Raffaele, Milan, Italy

Cisplatin, Capecitabine, Gemcitabine and Epirubicin or Docetaxel for Patients With Stage III or IV Pancreatic Cancer

First Posted Date
2009-08-27
Last Posted Date
2012-02-01
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
105
Registration Number
NCT00966706
Locations
🇮🇹

San Raffaele Scientific Institute, Milan, Italy

© Copyright 2025. All Rights Reserved by MedPath